Skip to main content

Table 6 Summary of adverse events in this clinical trial

From: Efficacy and safety of rhBMP/β-TCP in alveolar ridge preservation: a multicenter, randomized, open-label, comparative, investigator-blinded clinical trial

 

Test group (N = 43)

Control group (N = 45)

Total (N = 48)

Patients with adverse events

2 (4.65)

7 (15.56)

9 (10.23)

 95% CI

0.57, 15.81

6.49, 29.46

4.78, 18.53

p value*

  

0.1577

Severity of cases with adverse events

 Mild

2

9

11

 Moderate

0

2

2

 Severe

0

0

0

Relationship to the grafted material

 Definitely related

0

0

0

 Probably related

0

1

1

 Possibly related

0

0

0

 Possibly not related

0

0

0

 Definitely not related

2

10

12

 Unknown

0

0

0

  1. *Fisher’s exact test
  2. Patients with adverse events are presented as “number of patients (percentage of patients) [number of events]” and others are presented as “number of events”